Check-Cap Ltd. (MBAI)
NASDAQ: MBAI · Real-Time Price · USD
1.630
-0.040 (-2.40%)
At close: Mar 20, 2026, 4:00 PM EDT
1.690
+0.060 (3.68%)
After-hours: Mar 20, 2026, 6:11 PM EDT
Check-Cap Market Cap
Check-Cap has a market cap or net worth of $11.88 million as of March 20, 2026. Its market cap has increased by 156.37% in one year.
Market Cap
11.88M
Enterprise Value
10.60M
1-Year Change
156.37%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since March 19, 2015, Check-Cap's market cap has decreased from $58.80M to $11.88M, a decrease of -79.80%. That is a compound annual growth rate of -13.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 12.17M | 22.79% |
| Dec 31, 2025 | 9.91M | 71.14% |
| Dec 31, 2024 | 5.79M | -52.40% |
| Dec 29, 2023 | 12.17M | -5.04% |
| Dec 30, 2022 | 12.81M | -80.30% |
| Dec 31, 2021 | 65.04M | 205.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biodesix | 158.62M |
| Insight Molecular Diagnostics | 127.13M |
| FONAR | 120.89M |
| Exagen | 72.64M |
| Precipio | 50.04M |
| Inotiv | 12.93M |
| bioAffinity Technologies | 10.93M |
| XWELL | 7.61M |